Total Funding
91
78
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
22162
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Gary Clarke: Founder and Board DirectorPast Role: Trelar, Founder, Chief Executive Officer, President (Acquired) - Logistics, B2B Marketplace, SaaS- Richard Bernert: COO
About the Company
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis. They provide clinicians with novel tests and services aimed at improving diagnosis, management, and treatment of medical unmet needs using sophisticated bioinformatics and clinical research.
Precision Epigenomics is headquartered
in Tucson, Arizona and was founded in 2020.
